Point72 Asia (Singapore)’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,885	Closed	-$52K	–	1077
2024 Q3	$52K	Buy	+1,885	New	+$52K	0.01%	683
2024 Q1	–	Sell	-650	Closed	-$25.2K	–	1160
2023 Q4	$25.2K	Buy	+650	New	+$25.2K	0.01%	419